Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information
Learn about treatment options, treatment failure, associated adverse effects and more.
Choose from the criteria below to find an activity that fits you best.
Note: If you attended the live CE activity AND received CE credit (i.e. a pharmacist CE statement of credit with ACPE UAN 0221-9999-20-255-L04-P), you are NOT allowed to also receive credit for this home-study on-demand web activity.
Health system specialty pharmacies have traditionally tracked the same operational
metrics as independent and PBM-owned specialty pharmacies. However, while important,
these metrics fall short in demonstrating how medically-integrated specialty pharmacy
services improve clinical outcomes and lower the cost-of-care.
For this reason, leading health system specialty pharmacies have begun tracking disease-specific metrics and integrating them into clinical workflow. These data points help providers intervene more quickly to change patients’ therapy regimens when needed and drive adherence more effectively. They also support more productive engagement with industry stakeholders like health plans and pharmaceutical manufacturers.
During this webinar, health system pharmacy and physician leaders will share:
The target audience for this activity includes pharmacists. At the completion of this activity, the participant will be able to:
VP Clinical Affairs
Courtney Zitterkopf, PharmD
Memorial Hospital at Gulfport
Colleen Donahue, RN
Memorial Hospital at Gulfport
Release Date: May 12, 2020
Expiration Date: May 12, 2021
This activity is jointly provided by ProCE, Inc. and Trellis Rx. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-255-H04-P has been assigned to this home study knowledge-based activity. This activity is approved for 1.0 contact hours (0.1 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Statements of completion will be issued online at www.ProCE.com upon completion of the evaluation and post-test with a score of 70% or higher. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Ms. Donahue, Dr. Newman, and Dr. Zitterkopf have no relevant commercial or financial relationships to disclose.
No external support has been received for this activity.
The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.